Clinical Trial Update: Efficacy of PJS-539 for Adult Patients With COVID-19. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of PJS-539 in adults with COVID-19 and COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• PJS-539

Snippet

Sponsor: Hospital do Coracao | Conditions: Covid19, COVID-19 Pneumonia | Phase 2 | Status: COMPLETED